Levaquin
Levaquin Background:
Levaquin (levofloxacin) is an antibiotic that is manufactured by Ortho-McNeil, a subsidiary of Johnson & Johnson. Levaquin is within a class of antibiotics known as fluoroquinolones. Levaquin and other fluoroquinolones are prescribed to treat bacterial infections. While using fluoroquinolones, especially Levaquin, users have experienced high rates of tendon damage.
FDA Response:
Levaquin was heavily marketed without adequate warnings prior to 2008. In January of 2008, Public Citizen, a consumer advocacy group, filed a lawsuit requesting more detailed information regarding the risks associated with Levaquin. In July of 2008, the FDA required the manufacturers of fluoroquinolones, including Levaquin, to include a Black Box warning. A Black Box warning is the strongest warning available. Also, the FDA required that a guidebook be included with Levaquin. The guidebook describes the risks associated with taking Levaquin and advises the user to contact his or her doctor if a problem were to arise.
Levaquin Problems:
You may have been harmed by Levaquin if you have suffered the following:
- Tendonitis
- Tendon Rupture
- Tendon Damage
Levaquin Litigation:
James, Vernon & Weeks, P.A. seeks to protect the rights of individuals who have been harmed by Levaquin. James, Vernon & Weeks, P.A. represents individuals suffering from Levaquin on a contingency basis. Contingency basis means that there are never any legal fees unless James, Vernon & Weeks, P.A. wins compensation in your case.
